Page 42 - Read Online

Sugarbaker. J Cancer Metastasis Treat 2018;4:7 I http://dx.doi.org/10.20517/2394-4722.2017.67 Page 15 of 16

cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center
experience. Eur J Surg Oncol 2008;34:1246-52.
42. Yonemura Y, Fujimura T, Nishimura G, FallaR, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y, Sasaki T.
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-44.
43. Sugarbaker PH, Deraco M, Glehen O, Helm CW, Morris DL, Van der Speeten K. Cytoreductive Surgery and Perioperative Chemotherapy
for Peritoneal Surface Malignancy: Textbook and Video Atlas. Woodbury: Ciné-Med; 2012. p. 79-94.
44. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer
Treat Res 1996;82:359-74.
45. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by
peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370-5.
46. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y. Cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results
of a phase III randomized clinical trial. Ann Surg Oncol 2011;18:1575-81.
47. Valle M, Van der Speeten K, Garofalo A. Laparoscopic hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) in the
management of refractory malignant ascites: a multi-institution retrospective analysis in 52 patients. J Surg Oncol 2009;100:331-4.
48. Glehen O, Gilly FN, Cotte E. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism? Ann Surg
Oncol 2011;18:1524-6.
49. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computer tomography in patients with peritoneal carcinomatosis.
Cancer 1993;72:1631-6.
50. Garofalo A, Valle M. Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 2009;15:190-5.
51. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, Pisters PW, Feig B, Mansfield P. Does neoadjuvant treatment for
gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15:2684-91.
52. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith
DB, Langley RE, Verma M, Weeden S, Chua YJ; MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for
resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
53. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ, Buente H. Phase II study with the combination
etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989;7:1310-7.
54. Ajani JA, Ota DM, Jessup JM, Ames FC, McBride C, Boddie A, Levin B, Jackson DE, Roh M, Hohn D. Resectable gastric carcinoma.
An evaluation of preoperative and postoperative chemotherapy. Cancer 1991;68:1501-6.
55. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH. Neoadjuvant treatment of gastric cancer with
peritoneal dissemination. Eur J Surg Oncol 2006;32:661-5.
56. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29-42.
57. Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Taniguchi K, Nishimura GI, Miwa K, Ohyama S, Sugiyama K, Sasaki T, Endo
Y. Peritonectomy as a Treatment Modality for Patients with Peritoneal Dissemination from Gastric Cancer. In: Nakajima T, Yamaguchi T,
editors. Multimodality Therapy for Gastric Cancer. Tokyo: Springer Japan; 1999. p. 71-80.
58. Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M, Takao N, Yonemura Y. Outcome data of patients with peritoneal
carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy in a single specialized center. Ann Surg Oncol 2014;21:1147-52.
59. Kitayama J, Ishigami H, Yamaguchi H, Yamashita H, Emoto S, Kaisaki S, Watanabe T. Salvage gastrectomy after intravenous and
intraperitoneal paclitaxel 9PTX0 administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant
ascites. Ann Surg Oncol 2014;21:539-46.
60. Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y. Intraperitoneal docetaxel combined with S-1
for advanced gastric cancer with peritoneal dissemination. J Surg Oncol 2012;105:38-42.
61. Al-Batran SE, Homann N, Pauligk C, Illerhaus G, Martens UM, Stoehlmacher J, Schmalenberg H, Luley KB, Prasnikar N, Egger M,
Probst S, Messmann H, Moehler M, Fischbach W, Hartmann JT, Mayer F, Höffkes HG, Koenigsmann M, Arnold D, Kraus TW, Grimm
K, Berkhoff S, Post S, Jäger E, Bechstein W, Ronellenfitsch U, Mönig S, Hofheinz RD. Effect of neoadjuvant chemotherapy followed by
surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer. JAMA Oncol 2017;3:1237-
44.
62. Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, Clarke-Pearson D. Intraperitoneal catheter outcomes in a
phase 3 trial of intravenous vs. intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancers: a Gynecologic
Oncology Group study. Gynecol Oncol 2006;100:27-32.
63. Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y. Effects of neoadjuvant intraperitoneal/systemic
chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastases from gastric cancer. Int J Surg Oncol
2012;2012:148420.
64. Sugarbaker PH, Steves MA, Hafner GH. Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction
intraperitoneal chemotherapy. Reg Cancer Treat 1993;4:183-7.
65. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D. Prospective morbidity and mortality
assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal
mucinous malignancy. Ann Surg Oncol 2006;13:635-44.
66. Yan TD, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH. Morbidity and mortality assessment of cytoreductive surgery and
perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - a prospective study of 70 consecutive cases.
Ann Surg Oncol 2007;14:515-25.
67. Cunliffe WJ. The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer. Cancer Treat Res 1991;55:143-59.